Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease

作者: Timothy J. Price , Carol Beeke , Shahid Ullah , Robert Padbury , Guy Maddern

DOI: 10.1002/CNCR.29129

关键词: MetastasisOncologyMedicineCancerColorectal cancerMultivariate analysisSurvival analysisYoung adultInternal medicineChemotherapyRectum

摘要: BACKGROUND Previous reports have described differences in biology and outcome for colorectal cancer based on whether the primary is right or left sided. Further division by right, left, rectum even exact site has also been explored. Possible response to biological agents reported side of lesion. METHODS We explored South Australian registry metastatic assess if there were any patient characteristics, prognostic markers, treatment received outcomes was We exist colon site. RESULTS Two thousand nine hundred seventy-two patients analyzed. Thirty-five percent had a right-sided primary. The median overall survival entire group versus 9.6 20.3 months (P < .001). Multivariate analysis confirmed as an independent factor. For that active therapy, defined chemotherapy (± metastasis resection), 18.2 months; 29.4 Importantly, we found no suggestion major divided rectum, trends individual still supported division. CONCLUSIONS Patients with more negative factors indeed inferior compared those left-sided Our data further breakdown favor simple left-versus-right moving forward cancer. Cancer 2015;121:830–835. © 2014 American Society.

参考文章(15)
Dutrillaux B, Salmon Rj, Muleris M, Remvikos Y, Bara J, Pocard M, Poupon Mf, [Two colons--two cancers? Proximal or distal adenocarcinoma: arguments for a different carcinogenesis]. Bulletin Du Cancer. ,vol. 82, pp. 10- 21 ,(1995)
Eu Ling Neo, Carol Beeke, Timothy Price, Guy Maddern, Chris Karapetis, Colin Luke, David Roder, Robert Padbury, South Australian clinical registry for metastatic colorectal cancer Anz Journal of Surgery. ,vol. 81, pp. 352- 357 ,(2011) , 10.1111/J.1445-2197.2010.05589.X
Tomio Arai, Isamu Kino, Morphometrical and Cell Kinetic Studies of Normal Human Colorectal Mucosa Pathology International. ,vol. 39, pp. 725- 730 ,(1989) , 10.1111/J.1440-1827.1989.TB02421.X
K. Araki, Y. Furuya, M. Kobayashi, K. Matsuura, T. Ogata, H. Isozaki, Comparison of Mucosal Microvasculature between the Proximal and Distal Human Colon Journal of Electron Microscopy. ,vol. 45, pp. 202- 206 ,(1996) , 10.1093/OXFORDJOURNALS.JMICRO.A023433
Barry Iacopetta, Are there two sides to colorectal cancer International Journal of Cancer. ,vol. 101, pp. 403- 408 ,(2002) , 10.1002/IJC.10635
Eric R. Fearon, Bert Vogelstein, A genetic model for colorectal tumorigenesis Cell. ,vol. 61, pp. 759- 767 ,(1990) , 10.1016/0092-8674(90)90186-I
Dominik P. Modest, Christoph Schulz, Ludwig F. von Weikersthal, Detlef Quietzsch, Jobst C. von Einem, Andreas Schalhorn, Ursula Vehling-Kaiser, Rüdiger P. Laubender, Clemens Giessen, Sebastian Stintzing, Volker Heinemann, Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment). Anti-Cancer Drugs. ,vol. 25, pp. 212- 218 ,(2014) , 10.1097/CAD.0000000000000041
Peter Distler, Peter R. Holt, Are Right- and Left-Sided Colon Neoplasms Distinct Tumors? Digestive Diseases. ,vol. 15, pp. 302- 311 ,(1997) , 10.1159/000171605
S. Boeck, C. Schulz, C. Giessen, S. Stintzing, D. P. Modest, J. C. von Einem, V. Heinemann, L. Fischer von Weikersthal, U. Vehling-Kaiser, M. Stauch, H. G. Hass, T. Decker, S. Klein, S. Held, A. Jung, T. Kirchner, M. Haas, J. Holch, M. Michl, P. Aubele, Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial Journal of Cancer Research and Clinical Oncology. ,vol. 140, pp. 1607- 1614 ,(2014) , 10.1007/S00432-014-1678-3
Frank Benedix, Frank Meyer, Rainer Kube, Siegfried Kropf, Doerthe Kuester, Hans Lippert, Albert Roessner, Sabine Krüger, Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma. Pathology Research and Practice. ,vol. 208, pp. 592- 597 ,(2012) , 10.1016/J.PRP.2012.07.003